 | • レポートコード：MRC2-11QY11640 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は診断用放射性医薬品・造影剤のグローバル市場について調査・分析したレポートです。種類別（放射性医薬品、造影剤）市場規模、用途別（診断、治療、電離放射線ラジオイメージング、非電離放射線ラジオイメージング）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別診断用放射性医薬品・造影剤の競争状況、市場シェア ・世界の診断用放射性医薬品・造影剤市場：種類別市場規模 2015年-2020年（放射性医薬品、造影剤） ・世界の診断用放射性医薬品・造影剤市場：種類別市場規模予測 2021年-2026年（放射性医薬品、造影剤） ・世界の診断用放射性医薬品・造影剤市場：用途別市場規模 2015年-2020年（診断、治療、電離放射線ラジオイメージング、非電離放射線ラジオイメージング） ・世界の診断用放射性医薬品・造影剤市場：用途別市場規模予測 2021年-2026年（診断、治療、電離放射線ラジオイメージング、非電離放射線ラジオイメージング） ・北米の診断用放射性医薬品・造影剤市場分析：米国、カナダ ・ヨーロッパの診断用放射性医薬品・造影剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの診断用放射性医薬品・造影剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の診断用放射性医薬品・造影剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの診断用放射性医薬品・造影剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amag Pharmaceuticals、Bayer Healthcare、Bracco Imaging、Daiichi Sankyo、GE Healthcare、Guerbet、Lantheus、Mallinckrodt、Medtronic、Nordion ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Radiopharmaceuticals are a group of pharmaceutical drugs which have radioactivity. The contrast media plays an important role in enhancing the imaging facilities for better diagnosis.
The market drivers are technology advancements in medical imaging, increasing demand for image guided procedures and diagnostics and high prevalence of cancers and cardiac diseases.
Market Analysis and Insights: Global Diagnostic Radiopharmaceuticals & Contrast Media Market
The global Diagnostic Radiopharmaceuticals & Contrast Media market size is projected to reach US$ 8596.7 million by 2026, from US$ 8326.6 million in 2020, at a CAGR of 3.0%% during 2021-2026.
Global Diagnostic Radiopharmaceuticals & Contrast Media Scope and Market Size
Diagnostic Radiopharmaceuticals & Contrast Media market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Radiopharmaceuticals & Contrast Media market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Amag Pharmaceuticals
Bayer Healthcare
Bracco Imaging
Daiichi Sankyo
GE Healthcare
Guerbet
Lantheus
Mallinckrodt
Medtronic
Nordion
Market segment by Type, the product can be split into
Radiopharmaceuticals
Contrast Media
Market segment by Application, split into
Diagnostic
Therapeutic
Ionizing Radiation based Radioimaging
Non-Ionizing Radiation based Radioimaging
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diagnostic Radiopharmaceuticals & Contrast Media Revenue
1.4 Market by Type
1.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Radiopharmaceuticals
1.4.3 Contrast Media
1.5 Market by Application
1.5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic
1.5.3 Therapeutic
1.5.4 Ionizing Radiation based Radioimaging
1.5.5 Non-Ionizing Radiation based Radioimaging
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Perspective (2015-2026)
2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Growth Trends by Regions
2.2.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diagnostic Radiopharmaceuticals & Contrast Media Historic Market Share by Regions (2015-2020)
2.2.3 Diagnostic Radiopharmaceuticals & Contrast Media Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Diagnostic Radiopharmaceuticals & Contrast Media Market Growth Strategy
2.3.6 Primary Interviews with Key Diagnostic Radiopharmaceuticals & Contrast Media Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Radiopharmaceuticals & Contrast Media Players by Market Size
3.1.1 Global Top Diagnostic Radiopharmaceuticals & Contrast Media Players by Revenue (2015-2020)
3.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Players (2015-2020)
3.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Concentration Ratio
3.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Diagnostic Radiopharmaceuticals & Contrast Media Revenue in 2019
3.3 Diagnostic Radiopharmaceuticals & Contrast Media Key Players Head office and Area Served
3.4 Key Players Diagnostic Radiopharmaceuticals & Contrast Media Product Solution and Service
3.5 Date of Enter into Diagnostic Radiopharmaceuticals & Contrast Media Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Historic Market Size by Type (2015-2020)
4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020)
5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2015-2020)
6.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Players in North America (2019-2020)
6.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020)
6.4 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020)
7 Europe
7.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2015-2020)
7.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Players in Europe (2019-2020)
7.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020)
7.4 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020)
8 China
8.1 China Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2015-2020)
8.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Players in China (2019-2020)
8.3 China Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020)
8.4 China Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020)
9 Japan
9.1 Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2015-2020)
9.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Players in Japan (2019-2020)
9.3 Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020)
9.4 Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2015-2020)
10.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020)
10.4 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020)
11 India
11.1 India Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2015-2020)
11.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Players in India (2019-2020)
11.3 India Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020)
11.4 India Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2015-2020)
12.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Players in Central & South America (2019-2020)
12.3 Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020)
12.4 Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Amag Pharmaceuticals
13.1.1 Amag Pharmaceuticals Company Details
13.1.2 Amag Pharmaceuticals Business Overview
13.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Introduction
13.1.4 Amag Pharmaceuticals Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020))
13.1.5 Amag Pharmaceuticals Recent Development
13.2 Bayer Healthcare
13.2.1 Bayer Healthcare Company Details
13.2.2 Bayer Healthcare Business Overview
13.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Introduction
13.2.4 Bayer Healthcare Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)
13.2.5 Bayer Healthcare Recent Development
13.3 Bracco Imaging
13.3.1 Bracco Imaging Company Details
13.3.2 Bracco Imaging Business Overview
13.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Introduction
13.3.4 Bracco Imaging Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)
13.3.5 Bracco Imaging Recent Development
13.4 Daiichi Sankyo
13.4.1 Daiichi Sankyo Company Details
13.4.2 Daiichi Sankyo Business Overview
13.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Introduction
13.4.4 Daiichi Sankyo Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)
13.4.5 Daiichi Sankyo Recent Development
13.5 GE Healthcare
13.5.1 GE Healthcare Company Details
13.5.2 GE Healthcare Business Overview
13.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Introduction
13.5.4 GE Healthcare Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)
13.5.5 GE Healthcare Recent Development
13.6 Guerbet
13.6.1 Guerbet Company Details
13.6.2 Guerbet Business Overview
13.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Introduction
13.6.4 Guerbet Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)
13.6.5 Guerbet Recent Development
13.7 Lantheus
13.7.1 Lantheus Company Details
13.7.2 Lantheus Business Overview
13.7.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Introduction
13.7.4 Lantheus Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)
13.7.5 Lantheus Recent Development
13.8 Mallinckrodt
13.8.1 Mallinckrodt Company Details
13.8.2 Mallinckrodt Business Overview
13.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Introduction
13.8.4 Mallinckrodt Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)
13.8.5 Mallinckrodt Recent Development
13.9 Medtronic
13.9.1 Medtronic Company Details
13.9.2 Medtronic Business Overview
13.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Introduction
13.9.4 Medtronic Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)
13.9.5 Medtronic Recent Development
13.10 Nordion
13.10.1 Nordion Company Details
13.10.2 Nordion Business Overview
13.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Introduction
13.10.4 Nordion Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)
13.10.5 Nordion Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Diagnostic Radiopharmaceuticals & Contrast Media Key Market Segments
Table 2. Key Players Covered: Ranking by Diagnostic Radiopharmaceuticals & Contrast Media Revenue
Table 3. Ranking of Global Top Diagnostic Radiopharmaceuticals & Contrast Media Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Radiopharmaceuticals
Table 6. Key Players of Contrast Media
Table 7. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Regions (2015-2020)
Table 11. Global Diagnostic Radiopharmaceuticals & Contrast Media Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Diagnostic Radiopharmaceuticals & Contrast Media Market Growth Strategy
Table 17. Main Points Interviewed from Key Diagnostic Radiopharmaceuticals & Contrast Media Players
Table 18. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Players (2015-2020) (Million US$)
Table 19. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Players (2015-2020)
Table 20. Global Top Diagnostic Radiopharmaceuticals & Contrast Media Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Radiopharmaceuticals & Contrast Media as of 2019)
Table 21. Global Diagnostic Radiopharmaceuticals & Contrast Media by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Diagnostic Radiopharmaceuticals & Contrast Media Product Solution and Service
Table 24. Date of Enter into Diagnostic Radiopharmaceuticals & Contrast Media Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020) (Million US$)
Table 27. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Share by Type (2015-2020)
Table 28. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2021-2026)
Table 29. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Share by Application (2015-2020)
Table 30. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020) (Million US$)
Table 31. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Share by Application (2021-2026)
Table 32. North America Key Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Diagnostic Radiopharmaceuticals & Contrast Media Market Share (2019-2020)
Table 34. North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020) (Million US$)
Table 35. North America Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type (2015-2020)
Table 36. North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020) (Million US$)
Table 37. North America Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application (2015-2020)
Table 38. Europe Key Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Diagnostic Radiopharmaceuticals & Contrast Media Market Share (2019-2020)
Table 40. Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type (2015-2020)
Table 42. Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application (2015-2020)
Table 44. China Key Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2019-2020) (Million US$)
Table 45. China Key Players Diagnostic Radiopharmaceuticals & Contrast Media Market Share (2019-2020)
Table 46. China Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020) (Million US$)
Table 47. China Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type (2015-2020)
Table 48. China Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020) (Million US$)
Table 49. China Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application (2015-2020)
Table 50. Japan Key Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Diagnostic Radiopharmaceuticals & Contrast Media Market Share (2019-2020)
Table 52. Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type (2015-2020)
Table 54. Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Diagnostic Radiopharmaceuticals & Contrast Media Market Share (2019-2020)
Table 58. Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type (2015-2020)
Table 60. Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application (2015-2020)
Table 62. India Key Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2019-2020) (Million US$)
Table 63. India Key Players Diagnostic Radiopharmaceuticals & Contrast Media Market Share (2019-2020)
Table 64. India Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020) (Million US$)
Table 65. India Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type (2015-2020)
Table 66. India Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020) (Million US$)
Table 67. India Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Diagnostic Radiopharmaceuticals & Contrast Media Market Share (2019-2020)
Table 70. Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type (2015-2020)
Table 72. Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application (2015-2020)
Table 74. Amag Pharmaceuticals Company Details
Table 75. Amag Pharmaceuticals Business Overview
Table 76. Amag Pharmaceuticals Product
Table 77. Amag Pharmaceuticals Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)
Table 78. Amag Pharmaceuticals Recent Development
Table 79. Bayer Healthcare Company Details
Table 80. Bayer Healthcare Business Overview
Table 81. Bayer Healthcare Product
Table 82. Bayer Healthcare Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)
Table 83. Bayer Healthcare Recent Development
Table 84. Bracco Imaging Company Details
Table 85. Bracco Imaging Business Overview
Table 86. Bracco Imaging Product
Table 87. Bracco Imaging Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)
Table 88. Bracco Imaging Recent Development
Table 89. Daiichi Sankyo Company Details
Table 90. Daiichi Sankyo Business Overview
Table 91. Daiichi Sankyo Product
Table 92. Daiichi Sankyo Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)
Table 93. Daiichi Sankyo Recent Development
Table 94. GE Healthcare Company Details
Table 95. GE Healthcare Business Overview
Table 96. GE Healthcare Product
Table 97. GE Healthcare Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)
Table 98. GE Healthcare Recent Development
Table 99. Guerbet Company Details
Table 100. Guerbet Business Overview
Table 101. Guerbet Product
Table 102. Guerbet Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)
Table 103. Guerbet Recent Development
Table 104. Lantheus Company Details
Table 105. Lantheus Business Overview
Table 106. Lantheus Product
Table 107. Lantheus Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)
Table 108. Lantheus Recent Development
Table 109. Mallinckrodt Business Overview
Table 110. Mallinckrodt Product
Table 111. Mallinckrodt Company Details
Table 112. Mallinckrodt Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)
Table 113. Mallinckrodt Recent Development
Table 114. Medtronic Company Details
Table 115. Medtronic Business Overview
Table 116. Medtronic Product
Table 117. Medtronic Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)
Table 118. Medtronic Recent Development
Table 119. Nordion Company Details
Table 120. Nordion Business Overview
Table 121. Nordion Product
Table 122. Nordion Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)
Table 123. Nordion Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type: 2020 VS 2026
Figure 2. Radiopharmaceuticals Features
Figure 3. Contrast Media Features
Figure 4. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application: 2020 VS 2026
Figure 5. Diagnostic Case Studies
Figure 6. Therapeutic Case Studies
Figure 7. Ionizing Radiation based Radioimaging Case Studies
Figure 8. Non-Ionizing Radiation based Radioimaging Case Studies
Figure 9. Diagnostic Radiopharmaceuticals & Contrast Media Report Years Considered
Figure 10. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Regions: 2020 VS 2026
Figure 12. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Players in 2019
Figure 15. Global Top Diagnostic Radiopharmaceuticals & Contrast Media Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Radiopharmaceuticals & Contrast Media as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Diagnostic Radiopharmaceuticals & Contrast Media Revenue in 2019
Figure 17. North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Diagnostic Radiopharmaceuticals & Contrast Media Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Diagnostic Radiopharmaceuticals & Contrast Media Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
造影剤の世界市場（～2026年） A contrast agent is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast agents, enhance t…- マイクロバブル/超音波造影剤の世界市場（～2026年） Microbubbles/ultrasound contrast agents are small spherical bubbles comprised of three phases, namely innermost gas phase, shell material enclosing the gas phase, and outermost gas or liquid phase. These microbubbles have unique ability to respond to ultrasound; thereby used for ultrasound imaging a…
- 経口造影剤の世界市場（～2026年） Market Analysis and Insights: Global Oral Contrast Agent Market The global Oral Contrast Agent market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Oral Contrast Agent Scope and Market Size Oral Contrast Agent market is seg…
- 磁気共鳴画像法（MRI）用造影剤の世界市場（～2026年） Market Analysis and Insights: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market The global Contrast Agents for Magnetic Resonance Imaging (MRI) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Contrast …
- PET放射性医薬品の世界市場（～2026年） Market Analysis and Insights: Global PET Radiopharmaceuticals Market The global PET Radiopharmaceuticals market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global PET Radiopharmaceuticals Scope and Market Size PET Radiopharmaceu…